Oncology Impact Fund (Cayman) Management L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 258,730 shares at $37.16 ($8.9M) on 2021-11-22, disclosed to the SEC on 2021-11-24.
Open-market sale of $8.9M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,671 | $0 | 0.0% |
| 2 | $37.16 | 15,575 | $579K | 6.5% |
| 3 | $37.81 | 19,758 | $747K | 8.4% |
| 4 | $37.81 | 19,758 | $747K | 8.4% |
| 5 | $36.21 | 32,876 | $1.2M | 13.4% |
| 6 | $36.21 | 32,876 |
| $1.2M |
| 13.4% |
| 7 | $36.50 | 600 | $22K | 0.2% |
| 8 | $35.20 | 8,147 | $287K | 3.2% |
| 9 | $35.20 | 8,147 | $287K | 3.2% |
| 10 | $36.05 | 30,696 | $1.1M | 12.4% |
| 11 | $36.05 | 30,696 | $1.1M | 12.4% |
| 12 | $37.02 | 21,965 | $813K | 9.1% |
| 13 | $37.02 | 21,965 | $813K | 9.1% |
| Total | $34.35 avg | 258,730 | $8.9M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $8.7M | — | Filing → |